The Microbiome in Critical Illness: Firm Conclusions or Bact to Square One?

Digestive Diseases and Sciences

Volumn 61, Issue 6, 2016, Pages 1420-1421

  Lyons, John D ^a   Ford, Mandy L ^b   Coopersmith, Craig M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL RNA; CHECKPOINT KINASE INHIBITOR; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY; PROGRAMMED DEATH 1 LIGAND 1; RNA 16S; CULTURE MEDIUM;

ACTINOBACTERIA; BACTERIAL STRAIN; BACTEROIDETES; CRITICAL ILLNESS; EDITORIAL; FECES ANALYSIS; FIRMICUTES; FUSOBACTERIA; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; METAGENOMICS; MICROBIOME; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROTEOBACTERIA; SURVIVOR; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THERAPY; VENTILATED PATIENT; BACTERIAL LOAD; CULTURE MEDIUM; MICROBIOLOGICAL EXAMINATION; MICROFLORA;

BACTERIAL LOAD; BACTERIOLOGICAL TECHNIQUES; CRITICAL ILLNESS; CULTURE MEDIA; HUMANS; MICROBIOTA;

EID: 84959356884     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-016-4092-7     Document Type: Editorial

References (10)

1. Defazio J, Fleming ID, Shakhsheer B, Zaborina O, Alverdy JC. The opposing forces of the intestinal microbiome and the emerging pathobiome. Surg Clin North Am. 2014;94:1151–1161.
2. Ley RE, Peterson DA, Gordon JI. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell. 2006;124:837–848.
3. Shogan BD, Belogortseva N, Luong PM, et al. Collagen degradation and MMP9 activation by Enterococcus faecalis contribute to intestinal anastomotic leak. Sci Transl Med. 2015;7:286ra68.
4. Horai R, Zarate-Blades CR, Dillenburg-Pilla P, et al. Microbiota-dependent activation of an autoreactive T cell receptor provokes autoimmunity in an immunologically privileged site. Immunity. 2015;43:343–353.
5. Sivan A, Corrales L, Hubert N, et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science. 2015;350:1084–1089.
6. Vetizou M, Pitt JM, Daillere R, et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science. 2015;350:1079–1084.
7. Ojima M, Motooka D, Shimizu K, et al. Metagenomic analysis reveals dynamic changes of whole gut microbiota in the acute phase of intensive care unit patients. Dig Dis Sci. (Epub ahead of print). doi:10.1007/s10620-015-4011-3.
8. Shimizu K, Ogura H, Goto M, et al. Altered gut flora and environment in patients with severe SIRS. J Trauma. 2006;60:126–133.
9. Shimizu K, Ogura H, Hamasaki T, et al. Altered gut flora are associated with septic complications and death in critically ill patients with systemic inflammatory response syndrome. Dig Dis Sci. 2011;56:1171–1177.
10. Alverdy J, Gilbert J, Defazio JR, et al. Proceedings of the 2013 A.S.P.E.N. Research workshop: the interface between nutrition and the gut microbiome: implications and applications for human health [corrected]. JPEN. 2014;38:167–178.